Accelerant Holdings

NYSE:ARX

Insurance - Brokers

Financial Services
$19.90 -2.48%

-$0.33 today

Market cap
$4.33B
Beta
-0.77
P/E (TTM)
-2.1
EPS (TTM)
-$6.15
52W Low $9.18High $31.18

Volume 0.82M

Average 1.42M

ARX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Accelerant HoldingsNYSE: ARX

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How ARX compares with its peers on the latest reported figures

  • ARX's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for ARX, versus a peer median of 0.0%.
ARX Competitors Peer median
Research & Development for ARX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARXAccelerant HoldingsLTM Sep 2026$0 ——0.0%
BBUCBrookfield Business CorporationLTM Sep 2026$0 ——0.0%
CVBFCVB Financial Corp.LTM Sep 2026$0 ——0.0%
HGHamilton Insurance Group, Ltd.LTM Jun 2026$0 ——0.0%
TOWNTowneBankLTM Jun 2026$0 ——0.0%
SFNCSimmons First National CorporationLTM Sep 2026$0 ——0.0%
PRKPark National CorporationLTM Sep 2026$0 ——0.0%
BHFBrighthouse Financial, Inc.LTM Sep 2026$0 ——0.0%
HCIHCI Group, Inc.LTM Jun 2026$0 ——0.0%
GSHDGoosehead Insurance, IncLTM Jun 2026$0 ——0.0%
Peer median (excluding ARX) $0——0.0%

Competitors are the stored peer set for ARX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue103.2M213.1M329.7M597.7M879.5M
Cost of Revenue39.7M134.5M130.2M248.7M284.3M
Gross Profit63.5M78.6M199.5M349M595.2M
Gross Margin61.5%36.9%60.5%58.4%67.7%
Research & Development00000
Selling, General & Admin65.5M121.2M198.7M262.4M428.1M
Operating Expenses83.5M162.9M243.4M317M1.92B
Depreciation & Amortization1.6M5.8M14.5M26.6M35.2M
EBITDA(15.5M)(74.3M)(14.3M)91M(1.22B)
EBITDA Margin-15.0%-34.9%-4.3%15.2%-138.5%
Operating Income(20M)(84.3M)(43.9M)32M(1.32B)
Operating Margin-19.4%-39.6%-13.3%5.4%-150.3%
Interest Income200K2M20.9M50.5M79M
Interest Expense2.9M4.2M15.1M32.4M69M
Other Income / Expenses00000
Income Before Tax(20M)(84.3M)(43.9M)32M(1.32B)
Pre-Tax Margin-19.4%-39.6%-13.3%5.4%-150.3%
Income Tax Expense4.3M11.3M20.2M9.1M23.3M
Net Income(21.5M)(91.7M)(48.8M)27.2M(1.35B)
Net Margin-20.8%-43.0%-14.8%4.6%-154.0%
EPS (Basic)(0.13)(0.55)(0.30)0.17(7.49)
EPS (Diluted)(0.10)(0.55)(0.23)0.13(7.49)
Weighted Avg Shares162.5M165.6M162.5M162.5M190.26M
Weighted Avg Shares (Diluted)216.67M165.6M216.67M216.67M190.26M

Accelerant Holdings

NYSE:ARX

Intrinsic Alpha fair value

Locked

Current Price

$19.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.